Identification of inflammatory regulation roles of thalidomide/ruxolitinib in nucleus pulposus and construction of polyelectrolyte nanocomplexes-impregnated injectable hydrogels for synergistic intervertebral disk degeneration treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Musculoskeletal pain and rehabilitation · Spondyloarthritis Studies and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (80)
Show source-provided references
1. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions10.1038/nrrheum.2015.13 ↗
2. Intervertebral disc regeneration: do nutrients lead the way?10.1038/nrrheum.2014.91 ↗
3. The role of IL-1β and TNF-α in intervertebral disc degeneration10.1016/j.biopha.2020.110660 ↗
4. The prevalence of low back pain: a systematic review of the literature from 1966 to 199810.1097/00002517-200006000-00003 ↗
5. The lumbar intervertebral disc: from embryonic development to degeneration10.1016/j.jbspin.2013.07.012 ↗
6. Adjacent segment degeneration after fusion spinal surgery-a systematic review10.1007/s00264-018-4241-z ↗
7. Adjacent segment disease after instrumented fusion for adult lumbar spondylolisthesis: Incidence and risk factors10.1016/j.clineuro.2017.02.020 ↗
8. Complications and readmission after lumbar spine surgery in elderly patients: an analysis of 2,320 patients10.1016/j.spinee.2017.03.019 ↗
9. Comparative analysis of the biomechanics of the adjacent segments after minimally invasive cervical surgeries versus anterior cervical discectomy and fusion: A finite element study
10. Homing of mesenchymal stem cells in induced degenerative intervertebral discs in a whole organ culture system10.1097/BRS.0b013e3182544a8a ↗
11. Anti-inflammatory Chitosan/Poly-γ-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral disc10.1016/j.actbio.2016.06.013 ↗
12. The use of intradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial10.1097/00007632-200404150-00002 ↗
13. Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration
14. Side effects of corticosteroid injections: what’s new10.1016/j.jbspin.2012.12.001 ↗
15. Comprehensive review of therapeutic interventions in managing chronic spinal pain10.36076/ppj.2009/12/E123 ↗
16. The effect of spinal steroid injections for degenerative disc disease10.1016/j.spinee.2004.03.024 ↗
17. Histology and pathology of the human intervertebral disc
18. The twin spine study: contributions to a changing view of disc degeneration10.1016/j.spinee.2008.11.011 ↗
19. Association between sciatica and Propionibacterium acnes10.1016/S0140-6736(00)05109-6 ↗
20. Cross-sectional magnetic resonance imaging study of lumbar disc degeneration in 200 healthy individuals10.3171/2009.5.SPINE08675 ↗
21. ‘Stress’ distributions inside intervertebral discs. The effects of age and degeneration10.1302/0301-620X.78B6.0780965 ↗
22. Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions10.1038/s41413-020-00125-x ↗
23. Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells10.1002/jor.22274 ↗
24. Substance P stimulates production of inflammatory cytokines in human disc cells10.1097/BRS.0b013e3182a42bc2 ↗
25. Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop10.1038/s41413-020-0087-2 ↗
26. A role for TNFα in intervertebral disc degeneration: a non-recoverable catabolic shift10.1016/j.bbrc.2013.02.034 ↗
27. TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc10.1074/jbc.M111.264549 ↗
28. Role of cytokines in intervertebral disc degeneration: pain and disc content10.1038/nrrheum.2013.160 ↗
29. Inflammation in intervertebral disc degeneration and regeneration10.1098/rsif.2014.1191 ↗
30. Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue10.1097/01.brs.0000176188.40263.f9 ↗
31. Cytokine expression in the epidural space: a model of noncompressive disc herniation-induced inflammation10.1097/BRS.0b013e3182604baa ↗
32. Thalidomide10.1016/S0140-6736(04)16308-3 ↗
33. Lenalidomide and thalidomide in the treatment of chronic pain10.1517/14740338.2013.775242 ↗
34. Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain10.1007/s00210-011-0724-9 ↗
35. Successful treatment with low-dose thalidomide in a patient with both Behçet’s disease and complex regional pain syndrome type I: case report10.1097/01.RHU.0000062620.10630.21 ↗
36. Tofacitinib and TPCA-1 exert chondroprotective effects on extracellular matrix turnover in bovine articular cartilage ex vivo10.1016/j.bcp.2018.07.034 ↗
37. The emerging safety profile of JAK inhibitors in rheumatic disease10.1038/nrrheum.2017.23 ↗
38. Intradiscal delivery of celecoxib-loaded microspheres restores intervertebral disc integrity in a preclinical canine model10.1016/j.jconrel.2018.08.019 ↗
39. Growing a backbone - functional biomaterials and structures for intervertebral disc (IVD) repair and regeneration: challenges, innovations, and future directions10.1039/C9BM01288E ↗
40. TGF-β3-loaded graphene oxide - self-assembling peptide hybrid hydrogels as functional 3D scaffolds for the regeneration of the nucleus pulposus10.1016/j.actbio.2021.03.077 ↗
41. “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy10.1016/j.addr.2015.10.019 ↗
42. Engineered nanoparticles for drug delivery in cancer therapy10.1002/anie.201403036 ↗
43. Chitosan functionalized thermosponge nano-carriers for prolonged retention and local delivery of chymopapain at the nucleus pulposus in porcine discs ex vivo10.1039/C6RA17848K ↗
44. A new formyl peptide receptor-1 antagonist conjugated fullerene nanoparticle for targeted treatment of degenerative disc diseases10.1021/acsami.9b11783 ↗
45. Electrochemical nanoarchitectonics and layer-by-layer assembly: from basics to future10.1016/j.nantod.2015.02.008 ↗
46. In situ monitoring of MicroRNA replacement efficacy and accurate imaging-guided cancer therapy through light-up inter-polyelectrolyte nanocomplexes10.1002/advs.201700542 ↗
47. Acidic pH-induced charge-reversal nanoparticles for accelerated endosomal escape and enhanced microRNA modulation in cancer cells10.1039/C5CC10396G ↗
48. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer10.1016/j.biomaterials.2014.02.006 ↗
49. Gene-hydrogel microenvironment regulates extracellular matrix metabolism balance in nucleus pulposus
50. Injectable microcryogels reinforced alginate encapsulation of mesenchymal stromal cells for leak-proof delivery and alleviation of canine disc degeneration10.1016/j.biomaterials.2015.04.029 ↗
51. Biomaterials for intervertebral disc regeneration and repair10.1016/j.biomaterials.2017.03.013 ↗
52. Bioinspired hydrogels build a bridge from bench to bedside
53. Therapeutic effects of gefitinib-encapsulated thermosensitive injectable hydrogel in intervertebral disc degeneration10.1016/j.biomaterials.2018.01.016 ↗
54. Macroscale biomaterials strategies for local immunomodulation10.1038/s41578-019-0106-3 ↗
55. Using embedded alginate microparticles to tune the properties of in situ forming poly(N-isopropylacrylamide)-graft-chondroitin sulfate bioadhesive hydrogels for replacement and repair of the nucleus pulposus of the intervertebral disc10.1002/jsp2.1161 ↗
56. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization10.1016/j.jconrel.2006.11.024 ↗
57. The biocompatibility of PluronicF127 fibrinogen-based hydrogels10.1016/j.biomaterials.2009.12.050 ↗
58. Physical characterization of alginate-Pluronic F127 gel for endoluminal NABDs delivery10.1039/C3SM51873F ↗
59. Formulation and release behavior of doxycycline-alginate hydrogel microparticles embedded into pluronic F127 thermogels as a potential new vehicle for doxycycline intradermal sustained delivery10.1208/s12249-009-9361-8 ↗
60. Recent progress in biomedical applications of pluronic (PF127): pharmaceutical perspectives10.1016/j.jconrel.2015.04.032 ↗
61. Falco: high-speed FastQC emulation for quality control of sequencing data10.12688/f1000research.21142.1 ↗
62. NGS QC Toolkit: a toolkit for quality control of next generation sequencing data10.1371/journal.pone.0030619 ↗
63. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads10.1038/nbt.3122 ↗
64. Differential expression analysis for sequence count data10.1186/gb-2010-11-10-r106 ↗
65. Ultrasmall AgNP-impregnated biocompatible hydrogel with highly effective biofilm elimination properties10.1021/acsami.0c09414 ↗
66. Ligustilide alleviated IL-1β induced apoptosis and extracellular matrix degradation of nucleus pulposus cells and attenuates intervertebral disc degeneration in vivo10.1016/j.intimp.2019.01.004 ↗
67. A simple disc degeneration model induced by percutaneous needle puncture in the rat tail10.1097/BRS.0b013e31817c64a9 ↗
68. Effect of perfluorotributylamine-enriched alginate on nucleus pulposus cell: Implications for intervertebral disc regeneration10.1016/j.biomaterials.2015.12.013 ↗
69. Magnetic resonance classification of lumbar intervertebral disc degeneration10.1097/00007632-200109010-00011 ↗
70. An in vivo model of degenerative disc disease10.1016/S0736-0266(02)00098-0 ↗
71. Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions10.7150/thno.48987 ↗
72. Cell death in intervertebral disc degeneration10.1007/s10495-013-0839-1 ↗
73. Apoptosis, senescence, and autophagy in rat nucleus pulposus cells: Implications for diabetic intervertebral disc degeneration10.1002/jor.22289 ↗
74. Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration10.1093/abbs/gmw112 ↗
75. IL-6/YAP1/β-catenin signaling is involved in intervertebral disc degeneration10.1002/jcp.27065 ↗
76. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways10.1038/onc.2011.609 ↗
77. In colorectal cancer cells with mutant KRAS, SLC25A22-mediated glutaminolysis reduces DNA demethylation to increase WNT signaling, stemness, and drug resistance10.1053/j.gastro.2020.08.016 ↗
78. Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma10.3390/cancers11121883 ↗
79. The relationship between the Wnt/β-catenin and TGF-β/BMP signals in the intervertebral disc cell10.1002/jcp.22438 ↗
80. Enhancement of intervertebral disc cell senescence by WNT/β-catenin signaling-induced matrix metalloproteinase expression10.1002/art.27599 ↗